Search Within

Ahmet Dogan

Formats
  1. Meeting Abstract (242)
  2. Journal Article (166)
  3. Research Letter (20)
  4. Review (16)
  5. Book Section (14)
  6. Guidelines (5)
  7. Editorial (4)
  8. Correspondence (2)
  9. Miscellaneous (1)
Groups
  1. Department of Pathology and Laboratory Medicine (470)
  2. Department of Medicine (315)
  3. Hematologic Malignancies, Division of (313)
  4. Center for Hematologic Malignancies (307)
  5. Sloan Kettering Institute Postdocs (180)
  6. Lymphoma (171)

More Groups

People
  1. Steven Horwitz (101)
  2. Mikhail Roshal (98)
  3. Maria Arcila (91)
  4. Andrew Zelenetz (81)
  5. Alison Moskowitz (78)
  6. Anita Kumar (64)

More People

Years
  1. 2025 (17)
  2. 2024 (47)
  3. 2023 (56)
  4. 2022 (33)
  5. 2021 (38)
  6. 2020 (59)

More Years

Publications
  1. Blood (135)
  2. Laboratory Investigation (47)
  3. Modern Pathology (36)
  4. Journal of Clinical Oncology (15)
  5. Haematologica (14)
  6. Journal of Molecular Diagnostics (14)

More Publications

Publishers
  1. American Society of Hematology (147)
  2. Nature Publishing Group (74)
  3. Nature Research (38)
  4. Wiley Blackwell (27)
  5. American Society of Clinical Oncology (19)
  6. Elsevier Inc. (17)

More Publishers

Results (470)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Low grade B-cell lymphomas (LGBCL) show unique T-cell immunophenotypes and immune checkpoint marker expression suggesting distinct therapeutic vulnerabilities
    Meeting Abstract

    Isgor, I.; El Daker, S.; Galera, P.; Zhu, M.; Roshal, M.; Dogan, A.
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Multidimensional deep T-cell phenotyping defines immune response in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)
    Meeting Abstract

    Rozenova, K.; El Daker, S.; Baik, J.; Zhu, M.; Dogan, A.; Roshal, M.; Galera, P.
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • CD40 immunohistochemistry distinguishes between classic Hodgkin Lymphoma and anaplastic large cell lymphoma
    Meeting Abstract

    Spivey, T.; Bhurtel, H.; Baik, J.; Jungbluth, A.; Dogan, A.; Chan, A.
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • PET‐adapted therapy with nivolumab plus adriamycin, vinblastine, and dacarbazine for newly diagnosed stage III or IV Hodgkin Lymphoma
    Meeting Abstract

    Moskowitz, A.; Savage, K.; Feldman, T.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Genetic alterations in follicular lymphoma predict response to very low dose radiotherapy
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E.; Chan, A.; Lee, J.; Fregonese, B.; Hajj, C.; Cedarquist, G.; Hubbeling, H.; Ma, J.; Sarkar, R.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Long‐term follow-up of multicenter phase II trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in previously untreated patients with CLL/SLL
    Meeting Abstract

    Soumerai, J. D.; Dogan, A.; Seshan, V.; Flaherty, K.; Carter, J.; Hochberg, E.; Barnes, J. A.; Abramson, J. S.; Hamilton, A. M.; Noy, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • BRCA1/2 mutations impact on the development of breast implant‐associated lymphoma (BIA‐ALCL) in women with breast cancer reconstructed with textured breast implants
    Meeting Abstract

    Ghione, P.; Arcila, M.; Joseph, V.; Dogan, A.; Cordeiro, P.; Salles, G.; de Jong, D.; Horwitz, S.; Mandelker, D.; van Leeuwen, F.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of nivolumab plus adriamycin, vinblastine, dacarbazine (N‐AVD) as frontline therapy in older adults with Hodgkin lymphoma
    Meeting Abstract

    Torka, P.; Feldman, T.; Savage, K.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Transformations of marginal zone lymphomas and lymphoplasmacytic lymphomas: Report from the 2021 SH/eAHP workshop
    Journal Article

    Cook, J. R.; Amador, C.; Czader, M.; Duffield, A.; Goodlad, J.; Ott, G.; Xiao, W.; Dave, S.; Thakkar, D.; Thacker, E.; more...
    American Journal of Clinical Pathology (2023)

    Fulltext@MSK | Save
  • Transdifferentiation, phenotypic infidelity, progression, and transformation in T/NK-cell neoplasms: Report from the 2021 SH/EAHP workshop
    Review

    Amador, C.; Cook, J. R.; Czader, M.; Duffield, A.; Goodlad, J.; Nejati, R.; Ott, G.; Xiao, W.; Dave, S.; Wasik, M. A.; more...
    American Journal of Clinical Pathology (2023)

    Fulltext@MSK | Save